ARROWHEAD PHARMACEUTICALS, INC. Common Stock Shares Outstanding

Quick Answer

ARROWHEAD PHARMACEUTICALS, INC. reported Common Stock Shares Outstanding of 135.70 million shares for the year ending 2025.

  • ARROWHEAD PHARMACEUTICALS, INC. showed an increase of +9.1% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from ARROWHEAD PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on November 25, 2025.
  • XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 15 years of available data (2011 to 2025), ARROWHEAD PHARMACEUTICALS, INC.'s Common Stock Shares Outstanding has grown by 1,470.2%.
  • Historical annual values: Fiscal year 2025: 135.70 million shares | Fiscal year 2024: 124.38 million shares | Fiscal year 2023: 107.31 million shares | Fiscal year 2022: 105.96 million shares | Fiscal year 2021: 104.33 million shares | Fiscal year 2020: 102.38 million shares | Fiscal year 2019: 95.51 million shares | Fiscal year 2018: 88.51 million shares | Fiscal year 2017: 74.79 million shares | Fiscal year 2016: 69.75 million shares | Fiscal year 2015: 59.54 million shares | Fiscal year 2014: 54.66 million shares | Fiscal year 2013: 32.49 million shares | Fiscal year 2012: 13.58 million shares | Fiscal year 2011: 8.64 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: